Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 56 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START TrialCompletedNCT01537991Not applicable
• CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT01533727Phase 2
• A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer PatientsCompletedNCT01531790Phase 1
• Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLCCompletedNCT01528488Phase 2/3
• Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck CancerTerminatedNCT01528137Phase 1
• Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung CancerStatus unknownNCT01527864Phase 2
• Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung CancerTerminatedNCT01525446Early Phase 1
• Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.CompletedNCT01525199
• A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib ResponseCompletedNCT01523340
• Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or LongerCompletedNCT01522833
• A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung CancerCompletedNCT01519804Phase 2
• Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)TerminatedNCT01515969Phase 1
• Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung CancerCompletedNCT01514877Phase 2
• An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)CompletedNCT01512420
• First Line Gefitinib by FDG-PET Metabolic ResponseStatus unknownNCT01510990Phase 2
• Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung CancerCompletedNCT01510405
• Integrated Molecular Profiling in Advanced Cancers TrialActive, not recruitingNCT01505400
• Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung CancerWithdrawnNCT01504542Phase 2
• A Clinical Study Testing The Safety And Efficacy Of Crizotinib In East Asian Patients With Anaplastic Lymphoma Kinase (ALK) Positive Advanced Non-Small Cell Lung CancerWithdrawnNCT01500824Phase 2
• Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung CancerCompletedNCT01498562Phase 2
• A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line TreatmentStatus unknownNCT01497041Phase 2
• A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung CancerCompletedNCT01496742Phase 2
• Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung CancerCompletedNCT01494558Phase 2/3
• Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung CancerStatus unknownNCT01494415Phase 2
• Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung CancerCompletedNCT01493843Phase 2
• Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung CancerStatus unknownNCT01493011Not applicable
• An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung CancerCompletedNCT01488331
• KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line ChemotherapyTerminatedNCT01487174Phase 3
• Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT01486602Phase 1
• Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving ChemotherapyCompletedNCT01482182
• Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung CancerStatus unknownNCT01481259Phase 2/3
• Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung CancerCompletedNCT01480973Not applicable
• A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT01478685Phase 1
• Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance ImagingTerminatedNCT01473693
• Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung CancerTerminatedNCT01471964Phase 1/2
• Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR MutationsStatus unknownNCT01470716Phase 2
• A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)CompletedNCT01466647Phase 1
• Dose Escalation Of Icotinib In Previously Treated Patients With Routine DoseCompletedNCT01465243Phase 4
• Immunotherapy With Racotumomab in Advanced Lung CancerStatus unknownNCT01460472Phase 3
• A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersCompletedNCT01460134Phase 1
• A Feasibility Study of Oral Adjuvant Chemotherapy With S-1CompletedNCT01459185Phase 2
• Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung CancerCompletedNCT01457469Phase 1
• A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)CompletedNCT01456325Phase 3
• Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable DiseaseStatus unknownNCT01450553
• Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase InhibitorsWithdrawnNCT01449357Phase 2
• A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer PatientsTerminatedNCT01444118Phase 3
• Pemetrexed Followed by Docetaxel or in Reverse SequenceCompletedNCT01442909Phase 4
• Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC PatientsCompletedNCT01441752Phase 3
• -02341066 and PF-00299804 for Advanced Non-Small Cell Lung CancerTerminatedNCT01441128Phase 1
• Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung CancerCompletedNCT01427946Phase 1/2
• Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung CancerTerminatedNCT01426620Phase 2
• Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01424709Phase 2
• Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung CancersCompletedNCT01421953Not applicable
• Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)TerminatedNCT01419587Not applicable
• Efficacy and Safety Study of Afatinib to Treat Lung Cancer PatientsCompletedNCT01415011Phase 2
• Amatuximab for High Mesothelin CancersTerminatedNCT01413451Early Phase 1
• Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryTerminatedNCT01411098Phase 1
• Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR MutationsStatus unknownNCT01410214Phase 2
• A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung CancerTerminatedNCT01409681
• Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung CancerStatus unknownNCT01407822Phase 2/3
• MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung CancerStatus unknownNCT01405586Phase 3
• Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR MutationStatus unknownNCT01405079Phase 3
• Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase ExpressionStatus unknownNCT01401192Phase 2
• Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung CancerWithdrawnNCT01398124Not applicable
• Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC PatientsStatus unknownNCT01393080Not applicable
• Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01391260Phase 2
• Safety Study of MGA271 in Refractory CancerCompletedNCT01391143Phase 1
• Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung CancerWithdrawnNCT01383668Phase 1
• Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung CancerTerminatedNCT01383148Phase 2/3
• A Retrospective EGFR Mutation Status Study in Chinese NSCLC Patients Using Paired Plasma and Tissue SamplesStatus unknownNCT01382992
• Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial CarcinomasTerminatedNCT01380795Early Phase 1
• Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung CancerTerminatedNCT01379976Phase 3
• A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus ErlotinibTerminatedNCT01377376Phase 3
• Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing ChemotherapyTerminatedNCT01374100Not applicable
• Cisplatin and Pemetrexed With Radiation Followed by LobectomyTerminatedNCT01373463Phase 1
• Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)CompletedNCT01368848Phase 2
• Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)CompletedNCT01366131Phase 2
• A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous ChemotherapyCompletedNCT01364012Phase 3
• Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian CancerCompletedNCT01363947Phase 1
• A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung CancerCompletedNCT01362400Phase 2
• e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung CancerStatus unknownNCT01359436Not applicable
• An Observational Study of Lung Cancer Related Symptoms and Disease Control Rate in Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Chemotherapy With or Without Avastin (Bevacizumab)CompletedNCT01358942
• Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung CancerTerminatedNCT01356368Phase 2
• Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung CancerSuspendedNCT01356303Phase 2
• Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsCompletedNCT01352962Phase 1
• Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung CancerTerminatedNCT01348126Phase 2/3
• Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center ProgramsCompletedNCT01346280
• Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryActive, not recruitingNCT01345851Not applicable
• An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line TherapyCompletedNCT01343914
• First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung CancerTerminatedNCT01337154Phase 2
• Computer-Generated Quality of Life Assessment Program for Advanced Non-Small Cell Lung Cancer Patients (LUNL2)CompletedNCT01337102Not applicable
• Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid TumorsCompletedNCT01336842Phase 1
• Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT01336543Phase 2
• An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung CancerCompletedNCT01333007
• Epidemiological Study to Describe Non-small-cell Lung Carcinoma (NSCLC) Clinical Management Patterns in MENA. Lung-EPICLIN/ KSAStatus unknownNCT01330862
• Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug MonitoringCompletedNCT01326767Phase 3
• Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the BodyWithdrawnNCT01325753Not applicable
• Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) SubjectsCompletedNCT01323062Phase 1
• Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung CancerSuspendedNCT01320501Phase 4
• Clinical Trial on the Prevention of Thrombocytopenia After First-line ChemotherapyTerminatedNCT01319669Phase 2/3

← Carcinoma, Non-Small-Cell Lung overview